Biogen Balance Sheet Health
Financial Health criteria checks 5/6
Biogen has a total shareholder equity of $15.2B and total debt of $6.5B, which brings its debt-to-equity ratio to 43%. Its total assets and total liabilities are $26.6B and $11.4B respectively. Biogen's EBIT is $2.0B making its interest coverage ratio 49. It has cash and short-term investments of $1.1B.
Key information
43.0%
Debt to equity ratio
US$6.54b
Debt
| Interest coverage ratio | 49x |
| Cash | US$1.07b |
| Equity | US$15.21b |
| Total liabilities | US$11.35b |
| Total assets | US$26.57b |
Recent financial health updates
Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly
Jan 31
Is Biogen (NASDAQ:BIIB) Using Too Much Debt?
Oct 03Biogen (NASDAQ:BIIB) Has A Pretty Healthy Balance Sheet
Jun 28Is Biogen (NASDAQ:BIIB) A Risky Investment?
Mar 27Recent updates
Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
Apr 29Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Apr 28The Price Is Right For Biogen Inc. (NASDAQ:BIIB)
Apr 15We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings
Feb 21Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Feb 16Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)
Feb 14Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly
Jan 31Biotech And Pharma Diversification Pays Off
Jan 25Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult
Dec 26An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued
Oct 21Is Biogen (NASDAQ:BIIB) Using Too Much Debt?
Oct 03Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?
Jul 16Biogen (NASDAQ:BIIB) Has A Pretty Healthy Balance Sheet
Jun 28An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 23% Undervalued
Apr 14Is Biogen (NASDAQ:BIIB) A Risky Investment?
Mar 27Calculating The Intrinsic Value Of Biogen Inc. (NASDAQ:BIIB)
Jan 14Financial Position Analysis
Short Term Liabilities: BIIB's short term assets ($6.8B) exceed its short term liabilities ($3.2B).
Long Term Liabilities: BIIB's short term assets ($6.8B) do not cover its long term liabilities ($8.1B).
Debt to Equity History and Analysis
Debt Level: BIIB's net debt to equity ratio (35.9%) is considered satisfactory.
Reducing Debt: BIIB's debt to equity ratio has reduced from 43% to 43% over the past 5 years.
Debt Coverage: BIIB's debt is well covered by operating cash flow (25.2%).
Interest Coverage: BIIB's interest payments on its debt are well covered by EBIT (49x coverage).